Michael C. Perry

19.5k citations
196 papers · 15.6k · 3 hit papers · h-index 46

Impact in

  • Oncology top 0.2%
    • Lung Cancer Research Studies
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

Michael C. Perry

188 papers receiving 14.6k citations

Michael C. Perry's Hit Papers

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer 2006 · 4.9k citations
4.9k0+12+24Years since publication10002.0k3.0k4.0k

Peers

Michael C. Perry
Comparison fields: 5 of 172
  • Oncology 6.7k
  • Pulmonary and Respiratory Medicine 6.0k
  • Cancer Research 1.4k
  • Internal Medicine 193
  • Hepatology 429
Replace Douglass C. Tormey with:
Douglass C. Tormey United States
Maurie M. Markman United States
Oscar G. Arrieta Mexico
Martin H. Cohen United States
Muhammad Wasif Saif United States
David H. Johnson United States
Stefano Cascinu Italy
Sandro Barni Italy
Florian Lordick Germany
Gordon C. Jayson United Kingdom
Michael C. Perry relative to Douglass C. Tormey United States Douglass C. Tormey's profile →
Citations per field
00.5×2×2.8×
Douglass C. Tormey · 1×
Citations per year

Countries citing papers authored by Michael C. Perry

Since Specialization
Citations

This map shows the geographic impact of Michael C. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Perry more than expected).

Fields of papers citing papers by Michael C. Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Perry. The network helps show where Michael C. Perry may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael C. Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael C. Perry Line = papers co-authored together Michael C. Perry links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 196 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Hit paper breakdown →
20064878
2
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
Hit paper breakdown →
19921035
3
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
Hit paper breakdown →
1990975
4 1987400
5 2004371
6 2000349
7 2001345
8
American Society of Clinical Oncology educational book
2003311
9 2002308
10 2005295
11 2004232
12
Plasma microRNAs as novel biomarkers for early detection of lung cancer.
2011223
13 2001215
14 2001212
15 2006200
16 1991195
17 1989186
18 2007186
19 2003177
20 1989163

About Michael C. Perry

Michael C. Perry is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Pathology and Forensic Medicine and Hematology, having authored 196 papers that have together received 15.6k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (35 papers), Lung Cancer Treatments and Mutations (27 papers), Neuroendocrine Tumor Research Advances (25 papers), Cancer Treatment and Pharmacology (19 papers), Cancer therapeutics and mechanisms (17 papers), Lung Cancer Diagnosis and Treatment (13 papers), Lymphoma Diagnosis and Treatment (8 papers) and Breast Cancer Treatment Studies (8 papers). The work is most often cited by research in Oncology (6.7k citations), Pulmonary and Respiratory Medicine (6.0k citations), Cancer Research (1.4k citations), Internal Medicine (193 citations) and Hepatology (429 citations). Michael C. Perry has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include David H. Johnson, Robert J. Gray, Rogério Lilenbaum, Joan H. Schiller, Julie Renee Brahmer, Alan Sandler, Afshin Dowlati, Mark R. Green, Paul D. King and Walter L. Eaton. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Cancer, Clinical Lung Cancer and Journal of Polymer Science Part A Polymer Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact